Breaking News Instant updates and real-time market news.

SGEN

Seattle Genetics

$84.99

0.45 (0.53%)

04:55
10/04/19
10/04
04:55
10/04/19
04:55

Seattle Genetics management to meet with RBC Capital

Meetings to be held in Zurich and London on October 1-4 hosted by RBC Capital.

  • 04

    Oct

SGEN Seattle Genetics
$84.99

0.45 (0.53%)

09/29/19
PIPR
09/29/19
NO CHANGE
Target $95
PIPR
Overweight
Seattle Genetics price target raised to $95 from $75 at Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro raised his price target for Seattle Genetics to $95 from $75 after the company presented a "compelling" initial response rate of 71% for the combination of EV and pembrolizumab in 1st-line cisplatin-ineligible urothelial bladder cancer. While "admittedly early," these data compare very favorably to current standard of care and emerging IO combos, he contends. As such, the analyst believes it is reasonable to layer in this opportunity into his EV model, which he previously excluded. Catanzaro reiterates an Overweight rating on the shares and sees potential for further upside from additional UBC opportunities and possibly tucatinib in HER2+ mCRC.
09/30/19
STFL
09/30/19
NO CHANGE
Target $74
STFL
Hold
Seattle Genetics' EV-103 data 'stole the spotlight' at ESMO, says Stifel
Stifel analyst Stephen Willey, in a note to investors partially titled "EV-103 Data Steals the ESMO Spotlight," said he is incrementally more-positive on Seattle Genetics shares after the first presentation of Phase 1 EV-103 data, calling it "one of the more-impressive data sets observed at this ESMO meeting." Management seems ready and eager to leverage this preliminary data into an Phase 3 registrational trial intended to establish EV as a first-line standard-of-care therapy, said Willey, who believes EV is an important part of the longer-term diversification thesis for Seattle Genetics. He keeps a Hold rating on the stock, but raised his price target for Seattle Genetics shares to $74 from $69.
10/01/19
OPCO
10/01/19
NO CHANGE
Target $92
OPCO
Outperform
Seattle Genetics price target raised to $92 from $82 at Oppenheimer
Oppenheimer analyst Silvan Tuerkcan raised his price target for Seattle Genetics to $92 from $82 saying EV was "a show stopper in bladder cancer at ESMO." The analyst views three presentations as key, namely EV-103 combining EV+pembrolizumab in 1L cis-ineligible patients, the early profile of the "chemo"-free regimen that is looks compelling versus IMvigor130 data, and EV's profile in 2L that seems more competitive versus an ADC-targeting Trop-2 based on efficacy and safety. Tuerkcan reiterates an Outperform rating on the shares.
10/02/19
DBAB
10/02/19
NO CHANGE
Target $88
DBAB
Hold
Seattle Genetics price target raised to $88 from $79 at Deutsche Bank
Deutsche Bank analyst Konstantinos Aprilakis raised his price target for Seattle Genetics to $88 from $79 saying the strength of the company's pipeline was on full display at the recent European Society for Molecular Oncology meeting. The analyse added first-line urothelial carcinoma to his model but keeps a Hold rating on Seattle Genetics.

TODAY'S FREE FLY STORIES

10:20
12/05/19
12/05
10:20
12/05/19
10:20
General news
FX Action: The dollar »

FX Action: The dollar was…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/05/19
12/05
10:17
12/05/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/05/19
12/05
10:16
12/05/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/05/19
12/05
10:15
12/05/19
10:15
General news
U.S. factory orders increased 0.3% in October »

U.S. factory orders…

10:15
12/05/19
12/05
10:15
12/05/19
10:15
General news
Breaking General news story  »

Week of 11/29 EIA Natural…

10:15
12/05/19
12/05
10:15
12/05/19
10:15
General news
Breaking General news story  »

Week of 11/29 EIA Natural…

SAGE

Sage Therapeutics

$68.03

-81.19 (-54.41%)

10:14
12/05/19
12/05
10:14
12/05/19
10:14
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETN

Eaton

$91.29

0.17 (0.19%)

10:13
12/05/19
12/05
10:13
12/05/19
10:13
Conference/Events
JPMorgan U.S. machinery analyst to hold an analyst/industry conference call »

U.S. Machinery Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BUD

AB InBev

$79.02

-0.35 (-0.44%)

10:10
12/05/19
12/05
10:10
12/05/19
10:10
Options
Call sale in Anheuser Busch exits four-month trade for 99% loss »

Call sale in Anheuser…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CONE

CyrusOne

$60.90

-4.22 (-6.48%)

10:10
12/05/19
12/05
10:10
12/05/19
10:10
Periodicals
CyrusOne hit by ransomware attack, ZDNet reports »

Data center provider…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

VOLVY

Volvo

$0.00

(0.00%)

10:08
12/05/19
12/05
10:08
12/05/19
10:08
Hot Stocks
Volvo Group Venture Capital invests in Apex.AI, terms not disclosed »

Volvo Group Venture…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:08
12/05/19
12/05
10:08
12/05/19
10:08
Conference/Events
House Transportation & Intrastructure Committee to hold a hearing »

The Subcommittee of…

SAGE

Sage Therapeutics

$66.11

-83.11 (-55.70%)

10:04
12/05/19
12/05
10:04
12/05/19
10:04
Recommendations
Sage Therapeutics analyst commentary  »

Sage drug still active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$43.37

-0.14 (-0.32%)

, CMCSK

Comcast

$0.00

(0.00%)

10:03
12/05/19
12/05
10:03
12/05/19
10:03
Hot Stocks
Comcast's chief diversity officer David Cohen to step down »

In a regulatory filing,…

CMCSA

Comcast

$43.37

-0.14 (-0.32%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

FB

Facebook

$200.90

2.2 (1.11%)

, HES

Hess Corp.

$61.44

0.22 (0.36%)

10:03
12/05/19
12/05
10:03
12/05/19
10:03
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

FB

Facebook

$200.90

2.2 (1.11%)

HES

Hess Corp.

$61.44

0.22 (0.36%)

XFOR

X4 Pharmaceuticals

$10.69

0.62 (6.16%)

KSU

Kansas City Southern

$150.08

0.865 (0.58%)

WERN

Werner

$35.84

0.31 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ETSY

Etsy

$40.33

-1.85 (-4.39%)

, WAT

Waters

$223.70

-1.24 (-0.55%)

10:03
12/05/19
12/05
10:03
12/05/19
10:03
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

ETSY

Etsy

$40.33

-1.85 (-4.39%)

WAT

Waters

$223.70

-1.24 (-0.55%)

FFIV

F5 Networks

$136.50

-7.06 (-4.92%)

HOME

At Home Group

$5.50

-3.05 (-35.67%)

DFS

Discover

$82.89

-0.73 (-0.87%)

SYF

Synchrony

$37.25

-0.22 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 26

    Feb

YETI

Yeti

$32.86

1.46 (4.65%)

, BRO

Brown & Brown

$38.06

0.41 (1.09%)

10:03
12/05/19
12/05
10:03
12/05/19
10:03
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

YETI

Yeti

$32.86

1.46 (4.65%)

BRO

Brown & Brown

$38.06

0.41 (1.09%)

NKE

Nike

$95.20

1.48 (1.58%)

FB

Facebook

$200.84

2.14 (1.08%)

GOOGL

Alphabet Class A

$1,324.89

5.9 (0.45%)

GOOG

Alphabet

$1,327.00

5.54 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 19

    Dec

  • 26

    Feb

10:02
12/05/19
12/05
10:02
12/05/19
10:02
General news
Factory Orders data reported »

October Factory Orders up…

DLTR

Dollar Tree

$90.39

1.06 (1.19%)

10:00
12/05/19
12/05
10:00
12/05/19
10:00
Options
Early speculation drives call buyers to Dollar Tree »

Early speculation drives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MODN

Model N

$29.70

0.2 (0.68%)

09:58
12/05/19
12/05
09:58
12/05/19
09:58
Conference/Events
Model N management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

COST

Costco

$296.42

0.25 (0.08%)

, BYND

Beyond Meat

$71.81

-2.15 (-2.91%)

09:58
12/05/19
12/05
09:58
12/05/19
09:58
Hot Stocks
Beyond Meat higher after Bloomberg says Costco selling in select stores »

Shares of Beyond Meat…

COST

Costco

$296.42

0.25 (0.08%)

BYND

Beyond Meat

$71.81

-2.15 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

XXII

22nd Century

$1.02

-0.005 (-0.49%)

, TCNNF

Trulieve Cannabis

$0.00

(0.00%)

09:56
12/05/19
12/05
09:56
12/05/19
09:56
On The Fly
Rising High: 22nd Century enters CBD health market with Panacea investment »

In this week's "Rising…

XXII

22nd Century

$1.02

-0.005 (-0.49%)

TCNNF

Trulieve Cannabis

$0.00

(0.00%)

ACB

Aurora Cannabis

$2.49

0.01 (0.40%)

TBPMF

Tetra Bio Pharma

$0.00

(0.00%)

ALEAF

Aleafia Health

$0.00

(0.00%)

APHA

Aphria

$4.71

0.035 (0.75%)

CVSI

CV Sciences

$0.00

(0.00%)

CTST

CannTrust

$0.77

-0.0076 (-0.98%)

CGC

Canopy Growth

$18.64

0.25 (1.36%)

CRON

Cronos Group

$6.70

0.13 (1.98%)

CANN

General Cannabis

$0.00

(0.00%)

TLRY

Tilray

$18.79

0.02 (0.11%)

ZYNE

Zynerba

$5.99

(0.00%)

IGC

India Globalization Capital

$0.74

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

MMM

3M

$167.00

-0.105 (-0.06%)

09:55
12/05/19
12/05
09:55
12/05/19
09:55
Options
3M put volume heavy and directionally bearish »

Bearish flow noted in 3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

MEET

Meet Group

$5.19

0.035 (0.68%)

09:55
12/05/19
12/05
09:55
12/05/19
09:55
Conference/Events
Meet Group management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

PDCO

Patterson Companies

$21.91

1.69 (8.36%)

, SIG

Signet Jewelers

$18.20

1.55 (9.31%)

09:55
12/05/19
12/05
09:55
12/05/19
09:55
Options
Early notable gainers among liquid option names on December 5th »

Notable gainers among…

PDCO

Patterson Companies

$21.91

1.69 (8.36%)

SIG

Signet Jewelers

$18.20

1.55 (9.31%)

TSCO

Tractor Supply

$98.26

2.55 (2.66%)

FAST

Fastenal

$35.94

0.87 (2.48%)

DLTR

Dollar Tree

$90.80

1.47 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.